Healthcare Equipment and Supplies
Company Overview of BioSig Technologies, Inc.
BioSig Technologies, Inc., a development stage medical device company, engages in developing technology platform to minimize noise and artifacts from cardiac recordings during electrophysiology studies. Its product under development includes PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP system, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and ablation procedures. The company is also developing a library of software tools that are designed to be configured to fit the needs of electrophysiologists in various settin...
12424 Wilshire Boulevard
Los Angeles, CA 90025
Founded in 2009
Key Executives for BioSig Technologies, Inc.
Chief Executive Officer, President and Director
Total Annual Compensation: $103.1K
Co-Founder and Executive Chairman
Total Annual Compensation: $206.9K
Chief Financial Officer
Total Annual Compensation: $49.5K
Compensation as of Fiscal Year 2014.
BioSig Technologies, Inc. Key Developments
BioSig Technologies Appoints Jerome B. Zeldis to the Board of Directors
Apr 9 15
BioSig Technologies announced that Dr. Jerome B. Zeldis has joined the Company's Board of Directors, effective immediately. Dr. Zeldis has agreed to chair the Nominating Committee at the next regularly scheduled Board meeting. He is currently Chief Executive Officer of Celgene Global Health and Chief Medical Officer of Celgene Corporation.
BioSig Technologies Appoints Jay Millerhagen as Vice President, Clinical Affairs
Mar 23 15
BioSig Technologies, Inc. announced Jay Millerhagen has been appointed Vice President, Clinical Affairs. Mr. Millerhagen has over 25 years of experience developing, evaluating and launching new medical technologies and therapies. Most recently, Mr. Millerhagen served as Vice President, Clinical Affairs and Market Development for RESPICARDIA, Inc., in Minnetonka, MN. At RESPICARIDIA, he led clinical operations, staffing and site management leading to the pivotal IDE trial of the fully implantable remedÄ" System for the treatment of Central Sleep Apnea.
Jeffrey F. O'Donnell Rejoins BioSig Technologies' Board of Directors
Feb 5 15
BioSig Technologies announced Jeffrey F. O'Donnell, Sr. has rejoined BioSig's Board of Directors and will serve as Chairman of the Compensation Committee. Mr. O'Donnell sat on BioSig's Board of Directors from October 2011 through February 2014. Currently, Mr. O'Donnell serves as CEO and Chairman of the Board of privately-held Trice Medical.
Similar Private Companies By Industry
Recent Private Companies Transactions
December 19, 2014
August 15, 2014
Most Searched Private Companies
Sponsored Financial Commentaries